Guizhou Bailing Group Pharmaceutical Co Ltd Net Asset Quality Index
Guizhou Bailing Group Pharmaceutical Co Ltd net asset quality index. Guizhou Bailing Group Pharmaceutical Co Ltd (002424) has a Net Asset Quality Index of 53.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥5.95 Billion minus total liabilities of CN¥2.75 Billion yields net assets of CN¥3.20 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Guizhou Bailing Group Pharmaceutical Co net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Guizhou Bailing Group Pharmaceutical Co Ltd (2007–2025)
Net asset quality index of Guizhou Bailing Group Pharmaceutical Co Ltd from 2007 to 2025. This chart shows how Guizhou Bailing Group Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 19 annual periods from 2007 to 2025. As of March 2026, the index stands at 53.8%, representing net assets of CN¥3.20 Billion against total assets of CN¥5.95 Billion CNY. Check asset allocation strategy of Guizhou Bailing Group Pharmaceutical Co to assess the company's strategic physical and investment asset allocation.
Guizhou Bailing Group Pharmaceutical Co Ltd Net Asset Quality Index by Year (2007–2025)
Guizhou Bailing Group Pharmaceutical Co Ltd net asset quality index by year from 2007 to 2025. The table below presents the year-by-year Net Asset Quality Index for Guizhou Bailing Group Pharmaceutical Co Ltd from 2007 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Guizhou Bailing Group Pharmaceutical Co .
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 51.2% | CN¥3.17 Billion | CN¥6.20 Billion | CN¥3.02 Billion | ▲ +6.4 pp |
| 2024 | 44.8% | CN¥3.20 Billion | CN¥7.13 Billion | CN¥3.94 Billion | ▼ -3.2 pp |
| 2023 | 48.0% | CN¥3.53 Billion | CN¥7.35 Billion | CN¥3.82 Billion | ▼ -10.0 pp |
| 2022 | 58.0% | CN¥4.00 Billion | CN¥6.89 Billion | CN¥2.90 Billion | ▼ -3.1 pp |
| 2021 | 61.0% | CN¥3.96 Billion | CN¥6.49 Billion | CN¥2.53 Billion | ▲ +5.3 pp |
| 2020 | 55.7% | CN¥3.92 Billion | CN¥7.03 Billion | CN¥3.11 Billion | ▼ -2.9 pp |
| 2019 | 58.7% | CN¥4.14 Billion | CN¥7.05 Billion | CN¥2.91 Billion | ▼ -7.0 pp |
| 2018 | 65.7% | CN¥3.92 Billion | CN¥5.98 Billion | CN¥2.05 Billion | ▼ -6.2 pp |
| 2017 | 71.9% | CN¥3.47 Billion | CN¥4.82 Billion | CN¥1.36 Billion | ▼ -0.5 pp |
| 2016 | 72.4% | CN¥3.07 Billion | CN¥4.24 Billion | CN¥1.17 Billion | ▲ +2.6 pp |
| 2015 | 69.8% | CN¥2.68 Billion | CN¥3.84 Billion | CN¥1.16 Billion | ▲ +3.9 pp |
| 2014 | 65.9% | CN¥2.35 Billion | CN¥3.57 Billion | CN¥1.22 Billion | ▲ +4.7 pp |
| 2013 | 61.1% | CN¥2.13 Billion | CN¥3.48 Billion | CN¥1.35 Billion | ▼ -1.9 pp |
| 2012 | 63.0% | CN¥2.04 Billion | CN¥3.24 Billion | CN¥1.20 Billion | ▼ -1.2 pp |
| 2011 | 64.3% | CN¥1.94 Billion | CN¥3.02 Billion | CN¥1.08 Billion | ▼ -1.7 pp |
| 2010 | 66.0% | CN¥1.85 Billion | CN¥2.80 Billion | CN¥952.49 Million | ▲ +20.3 pp |
| 2009 | 45.7% | CN¥374.42 Million | CN¥819.90 Million | CN¥445.48 Million | ▲ +0.6 pp |
| 2008 | 45.0% | CN¥262.75 Million | CN¥583.47 Million | CN¥320.72 Million | ▲ +8.4 pp |
| 2007 | 36.6% | CN¥182.68 Million | CN¥498.55 Million | CN¥315.87 Million | — |